MyPathway study: a novel precision oncology multiple basket trial
6 Jul 2018
MyPathway study: a novel precision oncology multiple basket trial
Implementing precision medicine in oncology: The IMPACT trials
Lessons from long-term survey of stage I NSCLC
Editor's Choice for June 2018
Treating CLL with obinutuzumab
Emerging post-transplant therapeutic options for relapsed Hodgkin lymphoma
Improved OS with obinutuzumab in the CLL11 study
Update on bb2121 for relapsed myeloma
International cancer control plans
Updates in melanoma from ASCO 2018
Education, collaboration and communication in global cancer control
First-in-human phase 1 study of TAK-931 for solid tumours